Sports

Kroenke Sports & Entertainment announced September 1, 2026, that it has agreed to acquire a controlling stake in the Los Angeles Angels from the Moreno family, with the deal expected to close in Q1 2027 pending MLB approval. The reported $4 billion valuation covers the club and its regional sports network, though no official purchase price was disclosed; Arte Moreno will retain an undisclosed minority interest. The acquisition would add a Major League Baseball franchise to KSE's existing portfolio of six professional sports teams across the NFL, NBA, NHL, MLS, and English Premier League.

The African Restoration Bank filed a Gauteng High Court application on September 1 seeking to interdict SAFA's September 12 elective congress, naming SAFA, the Premier Soccer League, incumbent president Danny Jordaan, and challenger Sandile Zungu among the respondents. The application arrives alongside unresolved regional election disputes in at least three areas and a pending fraud trial in which Jordaan faces charges involving more than R1 million in SAFA funds. No hearing date has been confirmed and the court has yet to rule on urgency, standing, or interim relief, leaving the congress timeline uncertain.

The Washington Commanders have signed a multi-year agreement with commercial advisory firm Elevate to lead premium seating sales, hospitality strategy, and fan experience development for their planned stadium at the former RFK site. Full construction is scheduled to begin in spring 2027 and complete in spring 2030, backed by at least $2.7 billion in private investment from the team and approximately $1.06 billion in structured public funding approved by the D.C. Council in September 2025. Financial terms of the Elevate agreement were not disclosed, and the firm's mandate does not include naming rights or sponsorship.

Wheelchair basketball athlete Emily Oberst received a public warning from USADA after testing positive for canrenone, a metabolite of the acne medication spironolactone, in an out-of-competition sample collected August 6, 2026, without a required therapeutic use exemption. No competitive results were disqualified because the sample was collected outside competition, and Oberst has since obtained a TUE authorizing future use. The case illustrates how a prescribed, physician-directed medication can trigger an anti-doping finding when the required exemption paperwork is not secured in advance.